期刊论文

中文

现代中医药

1672-0571

2020

40

5

53-58

10.13424/j.cnki.mtcm.2020.05.014

国家自然科学基金面上资助项目(81804150,81574031) 中医药防治五官科疾病湖南省重点实验室建设项目(2017TP1018) 国家中医药管理局中医眼科学重点学科建设项目(ZK1801YK015) 湖南省研究生科研创新项目(CX2018B497)。

本校为第一机构

目的 观察散血明目片对糖尿病视网膜病变(diabetic retinopathy,DR)并发玻璃体积血(vitreous hemorrhage,VH)患者视网膜电图的影响.方法 60例(85眼)DR并发VH患者随机数字表法分为两组,对照组30例(42眼)行玻璃体切除治疗,术后1 mo玻璃体腔注射康柏西普,治疗组30例(43眼)在对照组的基础上于玻璃体切除手术后加用散血明目片口服治疗.治疗4mo后,观察两组患者最佳矫正视力(best corrected visual acuity,BCVA)、视网膜电图(electroretinogram,ERG)、光学相干断层成像(Optical coherence tomography,OCT)检测两组患者黄斑中心凹厚度(central macular thickness,CMT)情况.结果 两组患者治疗前后不同时间...

Objective To observe the influence of Sanxue Mingmu Tablet on diabetic retinopathy(DR) patients with vitreous hemorrhage(VH). Methods Sixty patients(85 eyes) with DR complicated with VH were divided into two groups by random number table method. 30 patients(42 eyes) in the control group received vitrectomy for treatment, 1 MO intravitreal injection of Compaccip, and 30 patients(43 eyes) in the treatment group were treated by oral administration of Sanxue Mingmu tablets after vitrectomy on the basis of the control group. Several BCVA(best corrected visual acuity), electroretinogram(ERG), and OC...